HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow-to-Debt Ratio
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow-to-Debt Ratio of -0.05x as of September 2025, meaning its operating cash flow of CN¥-187.38 Million could theoretically repay 0% of its total liabilities (CN¥4.03 Billion) in one year. Check HPGC Renmintongtai Pharmaceutical Corp (600829) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HPGC Renmintongtai Pharmaceutical Corp Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for HPGC Renmintongtai Pharmaceutical Corp across 28 annual periods. Also explore balance sheet size of HPGC Renmintongtai Pharmaceutical Corp for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year debt coverage analysis for HPGC Renmintongtai Pharmaceutical Corp. For market capitalisation and broader financial context, see HPGC Renmintongtai Pharmaceutical Corp (600829) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥299.98 Million | CN¥4.16 Billion | ▲ +167.7% |
| 2024 | 0.03x | CN¥115.44 Million | CN¥4.29 Billion | ▼ -62.2% |
| 2023 | 0.07x | CN¥332.99 Million | CN¥4.68 Billion | ▲ +6.5% |
| 2022 | 0.07x | CN¥307.33 Million | CN¥4.60 Billion | ▲ +230.5% |
| 2021 | -0.05x | CN¥-233.00 Million | CN¥4.55 Billion | ▼ -2123.4% |
| 2020 | 0.00x | CN¥-9.22 Million | CN¥4.00 Billion | ▲ +97.9% |
| 2019 | -0.11x | CN¥-411.60 Million | CN¥3.70 Billion | ▼ -186.0% |
| 2018 | 0.13x | CN¥366.45 Million | CN¥2.83 Billion | ▲ +200.4% |
| 2017 | 0.04x | CN¥139.07 Million | CN¥3.23 Billion | ▲ +196.0% |
| 2016 | 0.01x | CN¥46.01 Million | CN¥3.16 Billion | ▼ -87.8% |
| 2015 | 0.12x | CN¥333.99 Million | CN¥2.81 Billion | ▼ -65.8% |
| 2014 | 0.35x | CN¥392.58 Million | CN¥1.13 Billion | ▲ +417.2% |
| 2013 | -0.11x | CN¥-158.31 Million | CN¥1.44 Billion | ▼ -186.4% |
| 2012 | 0.13x | CN¥221.57 Million | CN¥1.75 Billion | ▲ +323.6% |
| 2011 | -0.06x | CN¥-108.30 Million | CN¥1.91 Billion | ▼ -155.1% |
| 2010 | 0.10x | CN¥162.99 Million | CN¥1.58 Billion | ▼ -72.5% |
| 2009 | 0.37x | CN¥447.82 Million | CN¥1.20 Billion | ▲ +818.3% |
| 2008 | -0.05x | CN¥-65.93 Million | CN¥1.27 Billion | ▼ -134.7% |
| 2007 | 0.15x | CN¥191.10 Million | CN¥1.27 Billion | ▼ -9.3% |
| 2006 | 0.17x | CN¥191.13 Million | CN¥1.16 Billion | ▼ -41.9% |
| 2005 | 0.28x | CN¥313.04 Million | CN¥1.10 Billion | ▲ +288.0% |
| 2004 | 0.07x | CN¥60.69 Million | CN¥828.09 Million | ▼ -47.2% |
| 2003 | 0.14x | CN¥71.65 Million | CN¥516.46 Million | ▼ -56.1% |
| 2002 | 0.32x | CN¥127.49 Million | CN¥403.72 Million | ▲ +881.2% |
| 2001 | 0.03x | CN¥14.79 Million | CN¥459.59 Million | ▼ -72.2% |
| 2000 | 0.12x | CN¥61.85 Million | CN¥534.74 Million | ▼ -42.9% |
| 1999 | 0.20x | CN¥58.21 Million | CN¥287.56 Million | ▲ +19.4% |
| 1998 | 0.17x | CN¥41.00 Million | CN¥241.76 Million | — |